英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Ezetimibe Impurity 78 |
依折麥布雜質(zhì)78 |
942485-60-1 |
詳細(xì)
|
Remdesivir Impurity 44 |
沙羅拉納 |
2096990-00-8 |
詳細(xì)
|
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate |
瑪巴洛沙韋 |
2136287-68-6 |
詳細(xì)
|
Idarubicin Impurity 6 |
依達(dá)比星雜質(zhì)6 |
196512-07-9 |
詳細(xì)
|
Dotinurad Impurity 23 |
多丁那德雜質(zhì)23 |
24295-27-0 |
詳細(xì)
|
Rotigotine Impurity 5(Rotigotine USP RC H) |
羅替戈汀雜質(zhì)5(羅替戈汀USP RC H) |
1148154-91-9 |
詳細(xì)
|
N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide |
沃渃拉贊 |
2514957-29-8 |
詳細(xì)
|
Safinamide Impurity 18 |
沙芬酰胺雜質(zhì)18 |
1000370-28-4 |
詳細(xì)
|
Azathioprine Impurity 2(Azathioprine EP Impurity B) |
硫唑嘌呤雜質(zhì)2(硫唑嘌呤EP雜質(zhì)B) |
157930-13-7 |
詳細(xì)
|
Moxifloxacin Impurity 62 |
莫西沙星雜質(zhì)62 |
855661-74-4 |
詳細(xì)
|
Sorafenib Impurity 57 |
索拉非尼雜質(zhì)57 |
1804875-27-1 |
詳細(xì)
|
Rivaroxaban Impurity 103 |
利伐沙班雜質(zhì)103 |
721401-51-0 |
詳細(xì)
|
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
比沙可啶 EP 雜質(zhì)C |
72901-16-7 |
詳細(xì)
|
Montelukast Impurity 26 |
孟魯司特雜質(zhì)26 |
1242260-05-4 |
詳細(xì)
|
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
比沙可啶EP雜質(zhì)E |
111664-35-8 |
詳細(xì)
|
Betamethasone Impurity 8(Betamethasone EP Impurity H) |
倍他米松雜質(zhì)8(倍他米松EP雜質(zhì)H) |
185613-71-2 |
詳細(xì)
|
Bisacodyl Impurity 1 |
比沙可啶雜質(zhì) |
13004-51-8 |
詳細(xì)
|
Bupivacaine Impurity 12 |
布比卡因雜質(zhì)12 |
2125995-25-5 |
詳細(xì)
|
21-Acetyloxy DeschloroMoMetasone Furoate |
糠酸莫米松雜質(zhì)52 |
83897-05-6 |
詳細(xì)
|
Mometasone Furoate Impurity V |
糠酸莫米松EP雜質(zhì)V |
109183-56-4 |
詳細(xì)
|
Fluticasone propionate Impurity K |
丙酸氟替卡松 雜質(zhì)K |
1174034-79-7 |
詳細(xì)
|
Fluticasone IMpurity |
氟替卡松雜質(zhì) |
397864-58-3 |
詳細(xì)
|
Fluticasone Impurity L |
氟替卡松雜質(zhì)L |
59860-80-9 |
詳細(xì)
|
Budesonide Impurity 11 |
布地奈德雜質(zhì)11 |
39672-76-9 |
詳細(xì)
|
16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate |
布地奈德雜質(zhì)12 |
77017-20-0 |
詳細(xì)
|
Budesonide Impurity 49 |
布地奈德雜質(zhì)49 |
76282-98-9 |
詳細(xì)
|
11β-hydroxy-16α,17α-isopropylidenedioxy-3-oxo-9α-fluoroandrosta-1,4-diene-17β-carboxylic acid |
曲安奈德雜質(zhì) 19 |
3800-28-0 |
詳細(xì)
|
Hydrocortisone 21-Butyrate |
21-丁酸氫化可的松 |
6677-99-2 |
詳細(xì)
|
9-Bromo-11,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate |
醋酸氟氫可的松上溴物 |
50733-54-5 |
詳細(xì)
|
Hydrocortisone Impurity 38 |
氫化可的松雜質(zhì)38 |
10184-70-0 |
詳細(xì)
|
11β-hydroxy-3,20-dioxopregn-4-en-21-al |
氫化可的松雜質(zhì) |
20287-97-2 |
詳細(xì)
|
Prednisolone Impurity 7 |
潑尼松龍雜質(zhì)7 |
61549-70-0 |
詳細(xì)
|
Loteprednol Impurity 5 |
氯替潑諾雜質(zhì) |
182069-19-8 |
詳細(xì)
|
Prednisone 21-Aldehyde |
潑尼松21 -醛 |
70522-55-3 |
詳細(xì)
|
Pregna-1,4-diene-3,20-dione,17-hydroxy- |
羥孕酮雜質(zhì) |
2477-61-4 |
詳細(xì)
|
tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)C |
2514949-81-4 |
詳細(xì)
|
Olmesartan Medoxomil Impurity G |
奧美沙坦MEDOXOMIL雜質(zhì)G |
761404-82-4 |
詳細(xì)
|
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
( 4-(2-羥異丙基)-2-丙基-1H-咪唑-5-甲酸(5-甲基-2-氧雜-1,3-二氧-4-甲基)酯(奧美沙坦酯雜質(zhì)) |
144978-05-2 |
詳細(xì)
|
Olmesartan Impurity 9 |
奧美沙坦酯雜質(zhì)9 |
849206-42-4 |
詳細(xì)
|
Olmesartan Medoxomil Impurity 17 |
美沙坦酯雜質(zhì)17 |
1418133-31-9 |
詳細(xì)
|
Methylprednisolone Acetate EP Impurity D |
醋酸甲潑尼龍EP雜質(zhì)D |
150899-33-5 |
詳細(xì)
|
Betamethasone Impurity 59 |
倍他米松雜質(zhì)59 |
5534-01-0 |
詳細(xì)
|
Beclometasone Dipropionate EP Impurity O |
丙酸倍氯米松EP雜質(zhì)O |
14527-61-8 |
詳細(xì)
|
Betamethasone 9,11-Epoxide Propionate |
倍氯米松雜質(zhì) |
205105-83-5 |
詳細(xì)
|
Fluocinolone Acetonide EP Impurity B |
醋酸氟輕松雜質(zhì)B |
65751-34-0 |
詳細(xì)
|
Cabozantinib Impurity 5 |
卡博替尼雜質(zhì)5 |
2377278-36-7 |
詳細(xì)
|
Cabozantinib impurity 51 |
卡博替尼雜質(zhì)51 |
2354-89-4 |
詳細(xì)
|
4-(aminomethyl)-2-chlorophenol hydrobromide |
4-(氨基甲基)-2-氯苯酚氫溴酸鹽 |
859517-85-4 |
詳細(xì)
|
Nintedanib impurity 03 |
尼達(dá)尼布雜質(zhì)03 |
2410284-90-9 |
詳細(xì)
|
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- |
N-(4-氨基苯基)-N-甲基-2-(哌嗪-1-基)乙酰胺(尼達(dá)尼布雜質(zhì)) |
2243384-71-4 |
詳細(xì)
|
Clopidogrel |
氯吡格雷 |
1314028-89-1 |
詳細(xì)
|
Clopidogrel Impurity 13 HCl;methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride |
氯吡格雷雜質(zhì)13 |
2173294-69-2 |
詳細(xì)
|
disodiumN-(carboxylatomethyl)-N-methylglycinate |
N-羧甲基-N-甲基甘氨酸二鈉鹽 |
71160-37-7 |
詳細(xì)
|
(3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine |
托法替尼-imZ22 |
2504210-32-4 |
詳細(xì)
|
Tipiracil Impurity 2 |
替比嘧啶雜質(zhì)C |
2101241-71-6 |
詳細(xì)
|
Tinidazole Impurity B |
替硝唑雜質(zhì)B |
25459-12-5 |
詳細(xì)
|
dithiodesethylcarbodenafil |
二硫代去乙基卡巴地那非(西地那非雜質(zhì)) |
1610830-81-3 |
詳細(xì)
|
Dexamethasone Impurity 9 |
地塞米松雜質(zhì)9 |
84449-15-0 |
詳細(xì)
|
Dexamethasone Impurity 17 |
地塞米松雜質(zhì)17 |
59860-99-0 |
詳細(xì)
|
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
甲潑尼龍雜質(zhì)24 |
93239-37-3 |
詳細(xì)
|
1H-Inden-1-one, 2,3-dihydro-3-hydroxy-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]- |
氯解磷定 |
2097683-70-8 |
詳細(xì)
|
Articaine-013 |
索非布韋 |
125088-93-9 |
詳細(xì)
|
Terazosin impurity |
達(dá)泊西汀 |
1260939-66-9 |
詳細(xì)
|
Dapoxetine impurity |
沙羅拉納 |
126113-24-4 |
詳細(xì)
|
CCMO-48 |
CCMO-48 |
1332391-11-3 |
詳細(xì)
|
Methyl (2E)-3-Cyclopentylprop-2-Enoate |
煙酸 |
136823-41-1 |
詳細(xì)
|
Remdesivir-010-S |
普拉格雷 |
1369903-46-7 |
詳細(xì)
|
5-Bromo-1-(2-fluorophenyl)-2-pentanone |
普拉格雷 |
1373350-56-1 |
詳細(xì)
|
1,5-Dibromo-1-(2-fluorophenyl)-2-pentanone |
伊沙佐米 |
1373350-57-2 |
詳細(xì)
|
synthesis-1 |
synthesis-1 |
1379423-29-6 |
詳細(xì)
|
1,3-Benzodioxole-5-carboxylic acid, 4-bromo-7-(phenylmethoxy)-, methyl ester |
艾地那非 |
142531-44-0 |
詳細(xì)
|
Methisosildenafil impure |
頭孢洛林酯 |
1425504-78-4 |
詳細(xì)
|
PSQ-IM-B |
馬來(lái)酸匹杉瓊 |
1430561-06-0 |
詳細(xì)
|
CINACALCET-001-R |
納呋拉啡 |
1630761-22-6 |
詳細(xì)
|
β-Alanine, N-(2-bromo-6-fluorophenyl)-, methyl ester |
駱駝蓬靈 |
1697691-31-8 |
詳細(xì)
|
4-Bromo-n-methoxy-n,3-dimethylbenzamide |
布林佐胺 |
170230-01-0 |
詳細(xì)
|
1-P-CHLOROPHENYL-1-CYCLOHEXANOL |
布林佐胺 |
17380-83-5 |
詳細(xì)
|
Benzoic acid, 4-bromo-3-methyl-, butyl ester |
替比拉西 |
1857027-20-3 |
詳細(xì)
|
synthesis-20 |
synthesis-20 |
1873303-87-7 |
詳細(xì)
|
Baricitinib Impurity 9 |
氟班色林 |
1911644-33-1 |
詳細(xì)
|
3-O-Methylnaltrexone Ethylene Ketal |
帕瑞昔布 |
197242-23-2 |
詳細(xì)
|
Acotiamide Impurity |
瑪巴洛沙韋 |
198470-83-6 |
詳細(xì)
|
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
異噁唑環(huán) |
1985606-53-8 |
詳細(xì)
|
1,6-2-HYDROXYBENZOYLAMINOHEXANE |
多巴胺 |
20073-95-4 |
詳細(xì)
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
卡博替尼 |
2037385-84-3 |
詳細(xì)
|
Butylphthalide impurity |
沙羅拉納 |
20871-40-3 |
詳細(xì)
|
FLUOROMETHOLONE IMPURITY 6 |
氟米龍雜質(zhì) |
382-52-5 |
詳細(xì)
|
Cholan-24-amide, 3,7,12-trihydroxy-N,N-dimethyl-, (3α,5β,7α,12α)- |
膽酸雜質(zhì) |
86678-85-5 |
詳細(xì)
|
Betamethasone Valerate EP Impurity H |
戊酸倍他米松EP雜質(zhì)H |
52619-18-8 |
詳細(xì)
|
Betamethasone Impurity 3 |
倍他米松雜質(zhì)3 |
18769-24-9 |
詳細(xì)
|
Betamethasone 17-butyrate |
倍他米松雜質(zhì) |
5534-14-5 |
詳細(xì)
|
3-OXO-4-AZAANDROST-5-EEN-17-BETA-CARBONZUUR |
3-氧代-4-氮雜-5-雄烷-17B-羧酸 |
103335-54-2 |
詳細(xì)
|
2-amino-6-methylbenzenecarboximidamide |
伊馬替尼雜質(zhì) |
1694987-11-5 |
詳細(xì)
|
Diazene, bis(4-fluorophenyl)-, (Z)- (9CI) |
卡博替尼雜質(zhì) |
51789-00-5 |
詳細(xì)
|
Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- |
卡博替尼雜質(zhì) |
190728-28-0 |
詳細(xì)
|
Cabozantinib Impurity 42 |
卡博替尼雜質(zhì)42 |
95262-10-5 |
詳細(xì)
|
4-[(E)-(4-hydroxyphenyl)azo]phenol |
4,4-二羥基偶氮苯(卡博替尼雜質(zhì)) |
51437-66-2 |
詳細(xì)
|
Cabozantinib Impurity 38 |
卡博替尼雜質(zhì)38 |
651054-52-3 |
詳細(xì)
|
1-(3-amino-4,5-dimethoxyphenyl)ethan-1-one |
1-(3-氨基-4,5-二甲氧基苯基)乙酮 |
134611-49-7 |
詳細(xì)
|
Linagliptin impurity KH-2 |
N-(2-乙酰基苯基)-2-(8-溴-7-(丁-2-炔-1-基)-3-甲基-2,6-二氧代-2,3,6,7-四氫-1H--嘌呤-1-基)乙酰胺(利格列汀雜質(zhì)) |
2279114-31-5 |
詳細(xì)
|